• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中心静脉导管无回血静脉造影图像及其可使用期限的回顾性分析。

A Retrospective Analysis of Venographic Images of a Central Venous Port without Blood Return and Its Usable Period.

机构信息

Department of Outpatient Chemotherapy, Osaka International Cancer Institute, Japan.

Department of Diagnostic and Interventional Radiology, Osaka International Cancer Institute, Japan.

出版信息

Intern Med. 2023 Oct 1;62(19):2827-2831. doi: 10.2169/internalmedicine.1249-22. Epub 2023 Feb 22.

DOI:10.2169/internalmedicine.1249-22
PMID:36823086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10602839/
Abstract

Objective In routine practice, central venous ports without blood return (CVPWBRs) are common. However, very few studies have reported on the viable period of CVPWBR use. We therefore investigated this period by retrospectively analyzing the venographic images of CVPWBRs. Methods We examined patients' venography through the CVPs at the point when they became CVPWBRs for the first time and analyzed the reasons for becoming CVPWBRs. For patients with minor complications of CVPs or normal venographic findings, we used the Kaplan-Meier method to evaluate the period for which such CVPWBRs could be used. Patients Eighty-four patients with malignancy whose CVPs became CVPWBRs for the first time between July 31, 2015, and March 12, 2020, were included. Results Nine (10.7%) patients had major complications that made the CVPs unusable. Thirty-three (39.3%) patients had minor complications, and the remaining 42 (50.0%) had normal venographic findings. For the 75 patients with minor complications or normal venographic findings who continued to use their CVPWBRs, the Kaplan-Meier method estimated that 25% of complications that might make it unusable would occur within 1,273 days. Conclusion There are two learning points in our study. First, venography is needed when the CVP becomes a CVPWBR for the first time due to the high risk, and second, CVPWBRs can be used for a relatively long period in patients without major complications. It is necessary to develop an appropriate follow-up management method for CVPWBRs in prospective studies.

摘要

目的

在常规实践中,经常会遇到无回血中心静脉导管(CVPWBR)的情况。然而,很少有研究报告 CVPWBR 使用的可行时间。因此,我们通过回顾性分析 CVPWBR 的静脉造影图像来研究这一时期。

方法

我们检查了首次出现 CVPWBR 时患者的 CVP 静脉造影,并分析了成为 CVPWBR 的原因。对于 CVP 有轻微并发症或静脉造影正常的患者,我们使用 Kaplan-Meier 方法评估这些 CVPWBR 可使用的时间。

患者

纳入 2015 年 7 月 31 日至 2020 年 3 月 12 日期间首次出现 CVPWBR 的 84 例恶性肿瘤患者。

结果

9 例(10.7%)患者有严重并发症导致 CVP 无法使用。33 例(39.3%)患者有轻微并发症,其余 42 例(50.0%)静脉造影正常。对于 75 例有轻微并发症或静脉造影正常的继续使用 CVPWBR 的患者,Kaplan-Meier 方法估计,在 1273 天内,有 25%的并发症可能使其无法使用。

结论

我们的研究有两个学习要点。首先,由于风险较高,当 CVP 首次因某种原因成为 CVPWBR 时,需要进行静脉造影;其次,在没有严重并发症的情况下,CVPWBR 可以相对较长时间使用。在前瞻性研究中,有必要为 CVPWBR 制定适当的随访管理方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70d1/10602839/3ef390f834a2/1349-7235-62-2827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70d1/10602839/3ef390f834a2/1349-7235-62-2827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70d1/10602839/3ef390f834a2/1349-7235-62-2827-g001.jpg

相似文献

1
A Retrospective Analysis of Venographic Images of a Central Venous Port without Blood Return and Its Usable Period.中心静脉导管无回血静脉造影图像及其可使用期限的回顾性分析。
Intern Med. 2023 Oct 1;62(19):2827-2831. doi: 10.2169/internalmedicine.1249-22. Epub 2023 Feb 22.
2
Subclavian vein versus arm vein for totally implantable central venous port for patients with head and neck cancer: a retrospective comparative analysis.锁骨下静脉与手臂静脉用于头颈部癌症患者完全植入式中心静脉导管:回顾性对比分析。
Cardiovasc Intervent Radiol. 2011 Dec;34(6):1222-9. doi: 10.1007/s00270-010-0051-4. Epub 2010 Dec 3.
3
A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute.对某一机构433例患者上臂端口的效用及并发症进行的回顾性分析。
Int J Clin Oncol. 2016 Jun;21(3):474-82. doi: 10.1007/s10147-015-0917-1. Epub 2015 Oct 27.
4
Three-dimensional gadolinium-enhanced MR venographic evaluation of patency of central veins in the thorax: initial experience.三维钆增强磁共振静脉造影评估胸部中心静脉通畅情况:初步经验
Radiology. 1999 Nov;213(2):555-60. doi: 10.1148/radiology.213.2.r99nv27555.
5
Placement of central venous port catheters and peripherally inserted central catheters in the routine clinical setting of a radiology department: analysis of costs and intervention duration learning curve.放射科常规临床环境中中心静脉端口导管和外周静脉穿刺中心静脉导管的放置:成本分析与干预持续时间学习曲线
Acta Radiol. 2017 Dec;58(12):1468-1475. doi: 10.1177/0284185117695664. Epub 2017 Apr 13.
6
Evaluation of radiologically implanted central venous port systems explanted due to complications.对因并发症而取出的放射学植入式中心静脉导管系统的评估。
J Vasc Access. 2011 Oct-Dec;12(4):306-12. doi: 10.5301/JVA.2011.7739.
7
[Percutaneous brachial access: a few simple considerations].[经皮肱动脉穿刺:几点简单的注意事项]
J Radiol. 2009 Jan;90(1 Pt 1):77-8. doi: 10.1016/s0221-0363(09)70085-x.
8
Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.用于长期化疗的完全植入式中心静脉通路导管。一项前瞻性研究,分析333个装置的并发症和成本,最短随访期为180天。
Ann Oncol. 1998 Jul;9(7):767-73. doi: 10.1023/a:1008392423469.
9
Tissue reaction induced by implanted venous access ports in adult patients after infection of the implantation site.植入部位感染后成年患者体内植入式静脉输液港引起的组织反应
Clin Hemorheol Microcirc. 2014;58(1):107-13. doi: 10.3233/CH-141881.
10
Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.经腋静脉置入全植入式静脉通路港用于头颈部恶性肿瘤患者的临床结局
J Vasc Access. 2019 Mar;20(2):134-139. doi: 10.1177/1129729818781270. Epub 2018 Jun 20.

本文引用的文献

1
Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review.患有或未患癌症患者的上肢深静脉血栓形成的临床病程:一项系统评价
Thromb Res. 2016 Apr;140 Suppl 1:S81-8. doi: 10.1016/S0049-3848(16)30104-9.
2
When one port does not return blood: two case reports of rare causes for misplaced central venous catheters.当一个端口不回血时:中心静脉导管位置异常罕见原因的两例病例报告
Braz J Anesthesiol. 2016 Jan-Feb;66(1):78-81. doi: 10.1016/j.bjane.2014.02.007. Epub 2014 Mar 6.
3
A retrospective statistical analysis of the late complications associated with central venous port placements.
一项关于中心静脉置管后期并发症的回顾性统计分析。
Jpn J Radiol. 2015 Jan;33(1):21-5. doi: 10.1007/s11604-014-0375-0. Epub 2014 Nov 30.
4
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review.临床疑似上肢深静脉血栓形成的诊断试验准确性:系统评价。
J Thromb Haemost. 2010 Apr;8(4):684-92. doi: 10.1111/j.1538-7836.2010.03771.x. Epub 2010 Feb 6.
5
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters.长期留置中心静脉导管相关的闭塞和血栓形成的管理。
Lancet. 2009 Jul 11;374(9684):159-69. doi: 10.1016/S0140-6736(09)60220-8.
6
Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study).阿替普酶治疗儿童中心静脉导管阻塞:一项前瞻性、开放标签、单臂研究(Cathflo Activase儿科研究)的结果
J Vasc Interv Radiol. 2006 Nov;17(11 Pt 1):1745-51. doi: 10.1097/01.RVI.0000241542.71063.83.
7
Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer.瑞替普酶治疗癌症患者中心静脉导管阻塞的有效性和安全性。
J Vasc Interv Radiol. 2004 Jan;15(1 Pt 1):39-44. doi: 10.1097/01.rvi.0000106385.63463.ec.
8
Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in cancer patients.低剂量尿激酶输注治疗癌症患者静脉通路装置的纤维蛋白阻塞
J Clin Oncol. 1997 Jul;15(7):2709-14. doi: 10.1200/JCO.1997.15.7.2709.
9
Mechanism and management of persistent withdrawal occlusion.持续性拔管后阻塞的机制与处理
Am Surg. 1988 Jun;54(6):326-8.